GSKvsMerck & Company

GSK and MRK stock compared: price, dividend, valuation and results, from SEC filings.

MRK

Merck & Company, Inc.

$132.81

Value $328B

-3.61%
MRK's page

GSK (GSK) has a market value of $96.9B and Merck & Company (MRK) $328B. Over the last year, with dividends, GSK moved +4.6% and MRK +41.8%. The P/E is 12.6 for GSK and 133.9 for MRK. Dividend yield: GSK 3.71%, MRK 2.56%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    GSK$96.9B

    MRK$328B

    MRK is 3.4 times GSK

  • Revenue, 12 months

    GSK$43.9B

    MRK$67.4B

    MRK is 1.5 times GSK

  • Net income, 12 months

    GSK$7.7B

    MRK$2.5B

    GSK is 3.1 times MRK

  • Operating margin

    GSK24.3%

    MRK–

  • ROIC

    GSK18.6%

    MRK3.9%

    14.7 points apart

  • P/E

    GSK12.6

    MRK133.9

    MRK is 11 times GSK

  • Dividend yield

    GSK3.7%

    MRK2.6%

    1.1 points apart

  • 5-year return

    GSK+40.7%

    MRK+86.3%

    45.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

GSK+40.7%

MRK+86.3%

10015020020222023202420252026
Returns by period
PeriodGSKWith dividendsMRKWith dividends
1 year since November 18, 2025+4.6%Price +0.9%+41.8%Price +37.7%
3 years since November 17, 2023+52.6%+15.1% a yearPrice +35.9%+43.1%+12.7% a yearPrice +30.5%
5 years since November 18, 2021+40.7%+7.1% a yearPrice +15.2%+86.3%+13.2% a yearPrice +59.9%
10 years since November 21, 2016+97.6%+7.0% a yearPrice +24.4%+203.1%+11.7% a yearPrice +123.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

GSKGSKMRKMerck & Company

Valuation

GSKMRK
Valuation
Price$47.82$132.81
Market value$96.9B$328B
Enterprise value (EV)$117B$372B
P/E12.6133.9
P/E, 5-year median13.114.8
P/B4.57.3
EV/EBIT11.078.2
Free cash flow yield8.9%4.5%

Results and growth

GSKMRK
Results and growth
Revenue, 12 months$43.9B$67.4B
Net income, 12 months$7.7B$2.5B
Free cash flow, 12 months$8.6B$14.7B
Earnings per share, 12 months$3.73$0.98
Revenue growth, year on year4.1%1.3%
Revenue growth a year, past+6.1%over 5 years+9.4%over 5 years
EPS growth a year, past-0.5%over 5 years+21.2%over 5 years

Margins and returns on capital

GSKMRK
Margins and returns on capital
Gross margin72.4%71.8%
Operating margin24.3%–
Net margin17.5%3.6%
ROIC18.6%3.9%
ROE35.8%5.2%

Balance sheet

GSKMRK
Balance sheet
Cash$4.6B$9.7B
Total debt$24.9B$53.8B
Net debt / EBITDA1.55.7
Interest cover–2.4×

Dividends and buybacks

GSKMRK
Dividends and buybacks
Dividend yield3.7%2.6%
Dividend per share, 12 months$1.78$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield1.9%1.6%
Shareholder yield5.6%4.1%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: GSK or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, GSK or Merck & Company?

By market value, Merck & Company ($328B) is about 3.4 times GSK ($96.9B), at today's prices.

How did GSK and MRK stock do over the last 10 years?

Since November 21, 2016, GSK's price moved +24.4% and MRK's +123.4%. With dividends: GSK +97.6% (+7.0% a year), MRK +203.1% (+11.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, GSK or MRK?

The dividend yield at today's price is 3.71% for GSK and 2.56% for Merck & Company. Over the last twelve months they paid $1.78 and $3.40 per share.

What is the P/E of GSK and MRK?

At today's price, the P/E is 12.6 for GSK and 133.9 for MRK. The median of the last five years was 13.1 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, GSK or Merck & Company?

Over the last twelve months, the net margin was 17.5% for GSK and 3.6% for Merck & Company, and the operating margin 24.3% and –. Revenue was $43.9B and $67.4B.

Which is the better investment, GSK or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.